Page 300 - Read Online

Page 10 of 11 Ghosh et al. Neuroimmunol Neuroinflammation 2018;5:38 I http://dx.doi.org/10.20517/2347-8659.2018.28

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Pandian JD, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke 2013;15:128-34.
2. Gourie-Devi M. Epidemiology of neurological disorders in India: review of background, prevalence and incidence of epilepsy, stroke,
Parkinson’s disease and tremors. Neurol India 2014;62:588-98.
3. Dalal PM, Malik S, Bhattacharjee M, Trivedi ND, Vairale J, Bhat P, Deshmukh S, Khandelwal K, Mathur VD. Population-based stroke
survey in Mumbai, India: incidence and 28-day case fatality. Neuroepidemiology 2008;31:254-61.
4. Sridharan SE, Unnikrishnan JP, Sukumaran S, Sylaja PN, Nayak SD, Sarma PS, Radhakrishnan K. Incidence, types, risk factors, and
outcome of stroke in a developing country: the Trivandrum Stroke Registry. Stroke 2009;40:1212-8.
5. Das SK, Banerjee TK, Biswas A, Roy T, Raut DK, Mukherjee CS, Chaudhuri A, Hazra A, Roy J. A prospective community-based study
of stroke in Kolkata, India. Stroke 2007;38:906-10.
6. Pandian JD, Bhullar RS, Kaur P, Dhillon S, Toor G, Singh Y. Trends in the use of intravenous recombinant tissue plasminogen activator
from northwest India. Int J Stroke 2012;7:363-4.
7. Corso G, Bottacchi E, Tosi P, Caligiana L, Lia C, Veronese Morosini M, Dalmasso P. Outcome predictors in first-ever ischemic stroke
patients: a population-based study. Int Sch Res Notices 2014;2014:904647.
8. Jickling GC, Sharp FR. Biomarker panels in ischemic stroke. Stroke 2015;46:915-20.
9. Maas MB, Furie KL. Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med 2009;3:363-83.
10. Jickling GC, Sharp FR. Blood biomarkers of ischemic stroke. Neurotherapeutics 2011;8:349-60.
11. Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cere-
brovascular disorders. Stroke 1989;20:1407-31.
12. Brott T, Marler JR, Olinger CP, Adams HP Jr, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M. Measurements of
acute cerebral infarction: lesion size by computed tomography. Stroke 1989;20:871-5.
13. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral
infarction. Lancet 1991;337:1521-6.
14. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke
and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
15. Kammersgaard LP, Olsen TS. Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study. Cerebrovasc Dis
2006;21:187-93.
16. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009;40:1082-90.
17. Corso G, Bottacchi E, Giardini G, Di Giovanni M, Meloni T, Pesenti Campagnoni M, Veronese Morosini M. Epidemiology of stroke in
northern Italy: the Cerebrovascular Aosta Registry, 2004-2008. Neurol Sci 2013;34:1071-81.
18. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within
the first year. Stroke 2003;34:122-6.
19. Steger C, Pratter A, Martinek-Bregel M, Avanzini M, Valentin A, Slany J, Stöllberger C. Stroke patients with atrial fibrillation have a
worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 2004;25:1734-40.
20. Ntaios G, Vemmos K, Lip GY, Koroboki E, Manios E, Vemmou A, Rodríguez-Campello A, Cuadrado-Godia E, Giralt-Steinhauer E,
Arnao V, Caso V, Paciaroni M, Diez-Tejedor E, Fuentes B, Pérez Lucas J, Arauz A, Ameriso SF, Hawkes MA, Pertierra L, Gómez-
Schneider M, Bandini F, Chavarria Cano B, Iglesias Mohedano AM, García Pastor A, Gil-Núñez A, Putaala J, Tatlisumak T, Barboza
MA, Athanasakis G, Makaritsis K, Papavasileiou V. Risk stratification for recurrence and mortality in embolic stroke of undetermined
source. Stroke 2016;47:2278-85.
21. Di Tullio MR, Qian M, Thompson JL, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip
GY, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators. Left ventricular
ejection fraction and risk of stroke and cardiac events in heart failure: data from the warfarin versus aspirin in reduced ejection fraction
trial. Stroke 2016;47:2031-7.
22. Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G, Remonda L, Sturzenegger M, Fischer U,
Baumgartner RW. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005;76:191-
5.
23. Musolino R, La Spina P, Granata A, Gallitto G, Leggiadro N, Carerj S, Manganaro A, Tripodi F, Epifanio A, Gangemi S, Di Perri R.
Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc Dis 2003;15:121-8.
24. Osmani AH, Durrani RK, Ara J. Comparison of outcome in different types of stroke due to cerebral ischemia. J Coll Physicians Surg
Pak 2010;20:42-6.
25. Huang WY, Weng WC, Chien YY, Wu CL, Peng TI, Chen KH. Predictive factors of outcome and stroke recurrence in patients with uni-
lateral atherosclerosis-related internal carotid artery occlusion. Neurol India 2008;56:173-8.
26. Koton S, Eizenberg Y, Tanne D, Grossman E. Trends in admission blood pressure and stroke outcome in patients with acute stroke and
transient ischemic attack in a national acute stroke registry. J Hypertens 2016;34:316-22.
27. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD. Acute blood glucose level and outcome from isch-